Navigation Links
Blocking Oncogene Can Stop Spread of Ovarian Cancer
Date:12/15/2008

Lab study showed it had effect on 60% Of malignant cells

MONDAY, Dec. 15 (HealthDay News) -- Blocking proteins produced by the oncogene MYC can stop the spread of ovarian cancer, researchers say.

An oncogene is a gene that has the potential to help cause cancer.

In up to 60 percent of human ovarian tumors, MYC is overly active. This causes the ovarian cells to produce excessive c-Myc, a protein regulator of other genes involved in cell growth, which leads to proliferation of the cancer cells.

University of California, Berkeley, researchers halted the spreading in lab cultures of human ovarian cancer cells with amplified MYC by using RNA interference (RNAi) to block c-Myc protein. They then used small interfering RNA (siRNA) to halt L-Myc and N-Myc proteins, a process that halted the growth of the non-amplified MYC tumors.

The therapies had no effect on lab cultures of normal ovarian surface epithelial cells, leading them to theorize that the RNAi and siRNA treatments are effective only when the MYC genes are abnormally active.

The findings are scheduled to be presented Monday at the American Society for Cell Biology annual meeting, in San Francisco.

More information

The National Ovarian Cancer Coalition has more about ovarian cancer.



-- Kevin McKeever



SOURCE: American Society for Cell Biology, news release, Dec. 14, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Blocking Potent Oxidant Could Prevent Morphine Tolerance
2. Blocking protein kills prostate cancer cells, inhibits tumor growth, Jefferson scientists find
3. Blocking the effect of inflammation-causing cells lowered prostate cancer cells invasion
4. Blocking signaling protein prevents prostate cancer spread, Jefferson scientists find
5. Pennsylvania Medical Society and AARP Criticize Senator Specter for Blocking Bill to Protect Access to Doctors and Improve Medicare
6. Blocking molecular pathway with whimsical name possible therapeutic target for pancreatic cancer
7. MicroRNA controls expression of oncogenes
8. Colon Cancer Oncogene Discovered
9. HIV denialists spread misinformation online -- consequences could be deadly; and more
10. Online Epidemic Gives Clues to Bird Flu Spread
11. Promising drug combination may help those with ocular melanoma that has spread
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blocking Oncogene Can Stop Spread of Ovarian Cancer
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes ... a mock evacuation of the facility as part of a disaster drill on October ... Hose EMS and Shelton City Emergency Manager, as well as the Connecticut Long ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released ... understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture ... Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that is ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...
(Date:10/12/2017)... , ... October 12, 2017 , ... The American College ... to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in ... , In honor of Morris F. Collen, a pioneer in the field of medical ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts ... Washington, D.C., for the 49th Congress of the International Society of Paediatric Oncology ... of the Center for Cancer and Blood Disorders at Children’s National, and ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/22/2017)... 22, 2017 AVACEN Medical (AVACEN) announced that ... successfully helping those with the widespread pain associated with ... Amanda in Essex, England commented, ... hair, experiencing no sleep at all, tremendous pain, with ... cannot recommend [the AVACEN 100] enough, how this has ...
Breaking Medicine Technology: